NCT03249220 (CBMS FIH) is a NA clinical trial of Placement of the CBMS Probe in Brain Injuries, sponsored by Carag AG.

Who is sponsoring NCT03249220?

NCT03249220 is sponsored by Carag AG.

What drugs are being tested in NCT03249220?

Interventions in NCT03249220: Placement of the CBMS Probe.

What condition does NCT03249220 study?

NCT03249220 studies Brain Injuries.

Is NCT03249220 still recruiting?

NCT03249220 is currently active, enrolled. Last updated 28 November 2025.

Last reviewed 2025-11-28 · How we verify

NCT03249220: CBMS FIH

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Clinical Pilot Study to Evaluate a New Multi-parameter Neuromonitoring Device in Brain-injured Patients

Active, enrolled NA Last updated 28 November 2025

What this trial tests

NA trial testing Placement of the CBMS Probe in Brain Injuries in 1 participant. Participants enrolled and being followed up; not accepting new ones.

Timeline

1 September 2020

Primary endpoint
30 June 2027

30 September 2027

Quick facts

Lead sponsor	Carag AG
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	device feasibility
Enrollment	1
Start date	1 September 2020
Primary completion	30 June 2027
Estimated completion	30 September 2027
Sites	2 locations across Switzerland

Drugs / interventions tested

Placement of the CBMS Probe

Conditions studied

Brain Injuries — all drugs for Brain Injuries →

Sponsor

Carag AG

Who can join

Adults 18 to 75, any sex, with Brain Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Clinical pilot study to evaluate a new multi-parameter neuromonitoring device that allows the measurement of regional cerebral blood flow (rCBF), intracranial pressure (ICP), brain temperature monitoring and ventricular cerebrospinal fluid (CSF) drainage in brain-injured patients.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Brain Injuries

Currently open trials in the same condition.

NCT06607523 — The Gut-Brain Axis During Neurorehabilitation; Prebiotic Treatment to Alter the Gut Microbiome and Neurologic Symptoms · NA · recruiting
NCT06873477 — Evaluation of Patients Affected by Traumatic and Hypoxic-ischemic Brain Injury · recruiting
NCT06511804 — Correlation Between Noninvasive Blood Vessel Functionality Parameters and Cerebral Hemodynamics in Neurocritical Care Pa · recruiting
NCT06863025 — Effects of Neurofeedback Training on Attentional Deficits in Patients With Acquired Brain Injury · NA · active not recruiting
NCT06571032 — Electroencephalography in the Management of Neuroelectric Stimulation in Patients With Severe Traumatic Brain Injuries · recruiting

Other Carag AG trials

Trials by the same sponsor.

NCT05278247 — Sensing Oxygen Saturations Using Abdominal NIRS With an Investigational Realtime Device (Songbird) · NA · not yet recruiting
NCT03706976 — NIRS to Monitor Abdominal Tissue Oxygen Saturation in Preterm Infants · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03249220 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Carag AG
Last refreshed: 28 November 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03249220.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing